Georgios Karanikas

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects
    Georgios Karanikas
    Department of Nuclear Medicin, University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 89:515-9. 2004
  2. doi No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis
    Georgios Karanikas
    Department of Nuclear Medicine, Medical University of Vienna, A 1090 Vienna, Austria
    Thyroid 18:7-12. 2008
  3. ncbi T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation
    Matthias Schuetz
    Department of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Anticancer Res 26:4591-6. 2006
  4. ncbi Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis
    Georgios Karanikas
    Departments of Nuclear Medicine and Pathophysiology, University of Vienna, A 1090 Vienna, Austria
    Clin Endocrinol (Oxf) 63:191-6. 2005
  5. ncbi FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals
    Alexander Becherer
    Department of Nuclear Medicine, Ludwig Boltzmann Institute for Nuclear Medicine, University of Vienna, Wahringer Gurtel 18 20, Vienna A 1090, Austria
    Eur J Radiol 54:284-8. 2005
  6. pmc Reliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO
    Christina Rami-Mark
    Radiochemistry and Biomarker Development Unit, Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, A 1090 Vienna, Austria Department of Inorganic Chemistry, University of Vienna, A 1090 Vienna, Austria
    Appl Radiat Isot 82:75-80. 2013
  7. ncbi Uptake of indium-111-labeled human polyclonal immunoglobulin G in pancreatic cancer: in vivo and in vitro studies
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, A 1090 Vienna, Austria
    Oncol Rep 9:353-7. 2002
  8. ncbi Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Oncol Rep 9:1009-13. 2002
  9. ncbi Tc-99m-labeled human polyclonal immunoglobulin G (HIG) scintigraphy in Sjögren's syndrome
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Austria
    Scand J Rheumatol 31:80-4. 2002
  10. ncbi Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Thromb Haemost 91:553-7. 2004

Collaborators

Detail Information

Publications23

  1. ncbi Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects
    Georgios Karanikas
    Department of Nuclear Medicin, University of Vienna, A 1090 Vienna, Austria
    J Clin Endocrinol Metab 89:515-9. 2004
    ....
  2. doi No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis
    Georgios Karanikas
    Department of Nuclear Medicine, Medical University of Vienna, A 1090 Vienna, Austria
    Thyroid 18:7-12. 2008
    ..The aim of our study was to evaluate the immunological benefit of Se administration in unselected AIT patients and thus address the question whether Se administration should generally be recommended for AIT patients...
  3. ncbi T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation
    Matthias Schuetz
    Department of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Anticancer Res 26:4591-6. 2006
    ..The lack of increased Th1 cytokine production accompanied by an increased Th2 cytokine production seems to be a special feature of HT patients with elevated CT levels that may reflect a pathogenetic mechanism for tumor initiation...
  4. ncbi Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis
    Georgios Karanikas
    Departments of Nuclear Medicine and Pathophysiology, University of Vienna, A 1090 Vienna, Austria
    Clin Endocrinol (Oxf) 63:191-6. 2005
    ..To our knowledge this is the first study systematically evaluating the correlation of possible parameters of disease activity such as changes in CD4 and CD8 T-cell cytokine production and of TPOAb titre...
  5. ncbi FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals
    Alexander Becherer
    Department of Nuclear Medicine, Ludwig Boltzmann Institute for Nuclear Medicine, University of Vienna, Wahringer Gurtel 18 20, Vienna A 1090, Austria
    Eur J Radiol 54:284-8. 2005
    ..This study prospectively investigates whether FDG PET can improve the prediction of viable tumour in post-chemotherapy seminoma residuals...
  6. pmc Reliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO
    Christina Rami-Mark
    Radiochemistry and Biomarker Development Unit, Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, A 1090 Vienna, Austria Department of Inorganic Chemistry, University of Vienna, A 1090 Vienna, Austria
    Appl Radiat Isot 82:75-80. 2013
    ..Its general applicability could be demonstrated and both [carbonyl-(11)C]WAY-100635 and [(11)C]-(+)-PHNO were prepared with high reliability and satisfying outcome...
  7. ncbi Uptake of indium-111-labeled human polyclonal immunoglobulin G in pancreatic cancer: in vivo and in vitro studies
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, A 1090 Vienna, Austria
    Oncol Rep 9:353-7. 2002
    ....
  8. ncbi Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Oncol Rep 9:1009-13. 2002
    ..In the staging of chemonaive patients with metastatic soft tissue sarcoma Tc-99m-tetrofosmin may provide some additional information...
  9. ncbi Tc-99m-labeled human polyclonal immunoglobulin G (HIG) scintigraphy in Sjögren's syndrome
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Austria
    Scand J Rheumatol 31:80-4. 2002
    ..To evaluate the usefulness of Tc-99m-HIG scintigraphy in patients with Sjögren's syndrome...
  10. ncbi Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Thromb Haemost 91:553-7. 2004
    ..According to the results of scintigraphy, the sequestration site by uncomplicated malaria-induced thrombocytopenia appears to be non-splenic and/or hepatic, yet diffuse...
  11. ncbi Beta-2 microglobulin as a diagnostic parameter in non-Hodgkin lymphoma: a comparative study with FDG-PET
    Daniel F Toth
    Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Anticancer Res 33:3341-5. 2013
    ....
  12. doi Radiolabeling of [18F]altanserin - a microfluidic approach
    Johanna Ungersboeck
    Department of Nuclear Medicine, Radiochemistry and Biomarker Development Unit, Medical University of Vienna, A 1090 Vienna, Austria
    Nucl Med Biol 39:1087-92. 2012
    ..The four main parameters evaluated were (1) precursor concentration, (2) reaction temperature, (3) bolus flow rate through the microreactor and (4) bolus volume...
  13. ncbi Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET
    Alexander Becherer
    Department of Nuclear Medicine, University of Vienna, Medical School, Vienna, Austria
    J Nucl Med 45:1161-7. 2004
    ..Based on the ability of NETs to store biogenic amines, this study evaluated whether 6-(18)F-fluoro-L-DOPA ((18)F-FDOPA) is a suitable PET tracer for NETs...
  14. ncbi T-lymphocyte cytokine production patterns in nonimmune severe hypothyroid state and after thyroid hormone replacement therapy
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Vienna, Austria
    Thyroid 14:488-92. 2004
    ..According to our results, the hypothyreotic state does not contribute to the reported changes in cytokine production patterns in Hashimoto's thyroiditis...
  15. ncbi Bone lesion detection with carrier-added 99mTc-EDTMP in comparison with 99mTc-DPD
    Barbara J Fueger
    Department of Nuclear Medicine, University of Vienna, Vienna, Austria
    Nucl Med Commun 25:361-5. 2004
    ..However, any advantage over conventional 99mTc-based tracers for bone scintigraphy in clinical use needs to be demonstrated in controlled trials...
  16. ncbi ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Austria
    Eur J Nucl Med Mol Imaging 29:312-8. 2002
    ....
  17. ncbi Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy
    Georgios Karanikas
    Department of Nuclear Medicine, University of Vienna, Vienna, Austria
    Am J Nephrol 24:41-5. 2004
    ..To investigate the possible changes in the renal tubular function in severe short-term hypothyroidism using (99m)Tc-MAG(3) renography...
  18. ncbi Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine
    Alexander Becherer
    Department of Nuclear Medicine, Medical School, University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Eur J Nucl Med Mol Imaging 30:1561-7. 2003
    ..It combines the good physical properties of (18)F with the pharmacological properties of MET and might therefore be a valuable PET radiopharmaceutical in brain tumour imaging...
  19. ncbi Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis
    Matthias Schuetz
    Department of Nuclear Medicine, Medical University of Vienna, Austria
    Anticancer Res 26:723-7. 2006
    ..The fact that both cases presented without evidence of nodular thyroid disease highlights the persistent diagnostic dilemma of CT screening programs...
  20. ncbi Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients
    Christian Pötzi
    Department of Nuclear Medicine, Medical University of Vienna, Austria
    Clin Endocrinol (Oxf) 65:519-23. 2006
    ....
  21. ncbi [11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme
    Christian Pötzi
    Department of Nuclear Medicine, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    J Neurooncol 84:305-14. 2007
    ..The aim of this study was to evaluate the value of [11C] methionine (MET) and [18F] fluorodeoxyglucose (FDG) PET in the follow-up of glioblastoma multiforme (GBM)...
  22. ncbi [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers
    Wolfgang Wadsak
    Department of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Eur J Nucl Med Mol Imaging 33:669-72. 2006
    ..In this study, we aimed to investigate for the first time the potency of [(18)F]FETO as a PET tracer for the adrenal cortex in humans...
  23. ncbi [18F]FETO: metabolic considerations
    Dagmar E Ettlinger
    Department of Nuclear Medicine, Medical University of Vienna, AKH Wien, Waehringer Guertel 18 20, A 1090, Vienna, Austria
    Eur J Nucl Med Mol Imaging 33:928-31. 2006
    ..The aims of this study were (1) to evaluate and compare the metabolic stability of MTO, ETO and FETO against esterases and (2) to investigate the metabolic pattern of FETO in vivo...